Skip to content

Medical emergency? What to do

New Algorithm for Ruptured Aneurysms Improves Mortality Rate

3-RXPublished June 12, 20093 min read

Key points

  • Researchers from the University of Washington in Seattle report that algorithms for the management of ruptured abdominal aortic aneurysm (rAAA) with a preference for endovascular repair (EVAR), serve as surrogates for an organized approach to managing the disease process and reducing overall mortality.
  • During the study period, 187 patients with rAAA underwent attempted repair at Harborview Medical Center.
  • In the post-protocol group, 73 percent of the patients presented with hypotension and there was no difference in the incidence of hypotension between EVAR and open groups.
  • About the Society for Vascular Surgery® The Society for Vascular Surgery (SVS) is a not-for-profit society that seeks to advance excellence and innovation in vascular health through education, advocacy, research and public awareness.

Researchers from the University of Washington in Seattle report that algorithms for the management of ruptured abdominal aortic aneurysm (rAAA) with a preference for endovascular repair (EVAR), serve as surrogates for an organized approach to managing the disease process and reducing overall mortality. These findings are from a study presented today at the 63rd Annual Meeting of the Society for Vascular Surgery®.

“The staff at Harborview Medical Center treat between 30 and 50 patients per year with rAAAs,” said Benjamin W. Starnes, MD, chief in the division of vascular surgery and associate professor of surgery at the University of Washington. “In this study we sought to evaluate the effect on mortality with the implementation of an algorithm to manage these patients with a preference for EVAR when feasible.”

During the study period, 187 patients with rAAA underwent attempted repair at Harborview Medical Center. Thirty-day mortality ratios were calculated and compared using Chi Square and Fisher’s Exact Test where appropriate, continuous variables were compared with a Mann-Whitney U test. Before implementation of the algorithm, (between July 1, 2002 and June 30, 2007) a total of 131 patients with rAAA were managed and treated. One-hundred and twenty-eight underwent surgical treatment and the 30-day mortality rate was 58 percent. Sixty-five percent of these patients were hypotensive at presentation.

A structured protocol that included early proximal control with an aortic occlusion balloon, permissive hypotension and endovascular repair when possible, was begun on July 1, 2007. Fifty-six patients with rAAA were managed and treated. Twenty-six underwent successful EVAR and 25 patients had open repair. Five patients underwent comfort care or died in the emergency department. Five patients in the EVAR group (19 percent) and 14 patients in the open group (56 percent), died during the follow-up period for an overall 30-day mortality rate of 37 percent.

In the post-protocol group, 73 percent of the patients presented with hypotension and there was no difference in the incidence of hypotension between EVAR and open groups. Average transfusion requirement for those undergoing EVAR was one unit (0-13) and for open repair, five units (0-19). The difference in transfusion requirement among survivors in each group was not different.

“Our algorithm reduced rAAA mortality by 36 percent (absolute risk reduction of 25 percent), said Dr. Starnes. “Further reduction in mortality is expected as improvements in endovascular techniques allow treatment of more patients with complex aortic anatomy.”

About the Society for Vascular Surgery®
The Society for Vascular Surgery (SVS) is a not-for-profit society that seeks to advance excellence and innovation in vascular health through education, advocacy, research and public awareness. SVS is the national advocate for 2,800 vascular surgeons dedicated to the prevention and cure of vascular disease.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Keep reading

Public Health

Parasitic DNA proliferates in aging tissues

The genomes of organisms from humans to corn are replete with "parasitic" strands of DNA that, when not suppressed, copy themselves and spread throughout the genome, potentially affecting health. Earlier this year…

4 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.